Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Annexin-I inhibits phospholipase A2 by specific interaction, not by substrate depletion.

Kim KM, Kim DK, Park YM, Kim CK, Na DS.

FEBS Lett. 1994 May 2;343(3):251-5.

2.

Inhibition of cytosolic phospholipase A2 by annexin I. Specific interaction model and mapping of the interaction site.

Kim SW, Rhee HJ, Ko J, Kim YJ, Kim HG, Yang JM, Choi EC, Na DS.

J Biol Chem. 2001 May 11;276(19):15712-9. Epub 2001 Feb 7.

3.
4.

Inhibition of human skin phospholipase A2 by "lipocortins" is an indirect effect of substrate/lipocortin interaction.

Bastian BC, Sellert C, Seekamp A, Römisch J, Pâques EP, Bröcker EB.

J Invest Dermatol. 1993 Sep;101(3):359-63.

8.

Annexin-I inhibits PMA-induced c-fos SRE activation by suppressing cytosolic phospholipase A2 signal.

Oh J, Rhee HJ, Kim S, Kim SB, You H, Kim JH, Na DS.

FEBS Lett. 2000 Jul 21;477(3):244-8.

9.

Inhibition of human cytosolic phospholipase A2 by human annexin V.

Buckland AG, Wilton DC.

Biochem J. 1998 Jan 15;329 ( Pt 2):369-72.

10.

Mechanism for the inhibitory and stimulatory actions of proteins on the activity of phospholipase A2.

Conricode KM, Ochs RS.

Biochim Biophys Acta. 1989 May 15;1003(1):36-43.

PMID:
2469472
11.

U937 cells deprived of endogenous annexin 1 demonstrate an increased PLA2 activity.

Solito E, Raguenes-Nicol C, de Coupade C, Bisagni-Faure A, Russo-Marie F.

Br J Pharmacol. 1998 Aug;124(8):1675-83.

12.

Purification and characterization of a mutant human platelet phospholipase A2 expressed in Escherichia coli. Cleavage of a fusion protein with cyanogen bromide.

Franken PA, Van den Berg L, Huang J, Gunyuzlu P, Lugtigheid RB, Verheij HM, De Haas GH.

Eur J Biochem. 1992 Jan 15;203(1-2):89-98.

13.

Kinetic and inhibition studies of phospholipase A2 with short-chain substrates and inhibitors.

Yuan W, Quinn DM, Sigler PB, Gelb MH.

Biochemistry. 1990 Jun 26;29(25):6082-94.

PMID:
2383571
14.

Partial coverage of phospholipid model membranes with annexin V may completely inhibit their degradation by phospholipase A2.

Speijer H, Jans SW, Reutelingsperger CP, Hack CE, van der Vusse GJ, Hermens WT.

FEBS Lett. 1997 Feb 3;402(2-3):193-7.

16.

Inhibition of phospholipase A2 by "lipocortins" and calpactins. An effect of binding to substrate phospholipids.

Davidson FF, Dennis EA, Powell M, Glenney JR Jr.

J Biol Chem. 1987 Feb 5;262(4):1698-705.

17.

Annexin 1: more than an anti-phospholipase protein.

Parente L, Solito E.

Inflamm Res. 2004 Apr;53(4):125-32. Epub 2004 Mar 18. Review.

PMID:
15060718
19.

Effects of antiflammins on transglutaminase and phospholipase A2 activation by transglutaminase.

Moreno JJ.

Int Immunopharmacol. 2006 Feb;6(2):300-3. Epub 2005 Aug 31.

PMID:
16399636

Supplemental Content

Support Center